英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

impossibility    音标拼音: [ɪmp,ɔsɪb'ɪlɪti]
n. 不可能;不可能的事

不可能;不可能的事

impossibility
n 1: incapability of existing or occurring [synonym:
{impossibility}, {impossibleness}] [ant: {possibility},
{possibleness}]
2: an alternative that is not available [synonym: {impossibility},
{impossible action}]

Impossibility \Im*pos`si*bil"i*ty\, n.; pl. {Impossibilities}.
[L. impossibilitas: cf. F. impossibilit['e].]
1. The quality of being impossible; impracticability.
[1913 Webster]

They confound difficulty with impossibility.
--South.
[1913 Webster]

2. An impossible thing; that which is not possible; that
which can not be thought, done, or endured.
[1913 Webster]

Impossibilities! O, no, there's none. --Cowley.
[1913 Webster]

3. Inability; helplessness. [R.] --Latimer.
[1913 Webster]

{Logical impossibility}, a condition or statement involving
contradiction or absurdity; as, that a thing can be and
not be at the same time. See {Principle of Contradiction},
under {Contradiction}.
[1913 Webster]


请选择你想看的字典辞典：
单词字典翻译
Impossibility查看　Impossibility　在百度字典中的解释百度英翻中〔查看〕
Impossibility查看　Impossibility　在Google字典中的解释Google英翻中〔查看〕
Impossibility查看　Impossibility　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • ENJAYMO® (sutimlimab-jome) | Cold Agglutinin Disease Treatment
    ENJAYMO is the first and only FDA-approved treatment for people with cold agglutinin disease (CAD) to help decrease the need for red blood cell transfusion For U S Residents Only ENJAYMO Patient Solutions ( 1-833-223-2428 )
  • Sutimlimab - Wikipedia
    Sutimlimab, sold under the brand name Enjaymo, is a monoclonal antibody that is used to treat adults with cold agglutinin disease (CAD) [ 1 ] [ 3 ] [ 4 ] It is given by intravenous infusion [ 1 ] Sutimlimab prevents complement-enhanced activation of autoimmune human B cells in vitro
  • Enjaymo: Uses, Dosage, Side Effects Warnings - Drugs. com
    Enjaymo is a prescription medicine that affects your immune system Enjaymo can lower the ability of your immune system to fight infections People who take Enjaymo may have an increased risk of getting infections caused by certain kinds of bacteria such as Neisseria meningitides, Streptococcus pneumoniae, and Haemophilus influenzae
  • HIGHLIGHTS OF PRESCRIBING INFORMATION . . . - Sanofi
    ENJAYMO intravenously weekly for the first two weeks, with administration every two weeks thereafter Administer ENJAYMO at the recommended dosage regimen time points, or within two days of these time points If a dose is missed, administer as soon as possible; thereafter, resume dosing every two weeks
  • ENJAYMO® (sutimlimab-jome) | Healthcare Professional Website
    ENJAYMO, a proximal classical complement C1s inhibitor, increases susceptibility to serious infections, including those caused by encapsulated bacteria e g Neisseria meningitidis (any serogroup, including non-groupable strains), Streptococcus pneumoniae, and Haemophilus influenzae type B
  • Enjaymo | European Medicines Agency (EMA)
    Enjaymo is a medicine for treating haemolytic anaemia (excess breakdown of red blood cells) in adults with cold agglutinin disease (CAD) CAD is a rare blood disorder where the immune system (the body’s natural defence) recognises red blood cells as foreign and attacks them
  • DailyMed - ENJAYMO- sutimlimab-jome injection, solution . . .
    ENJAYMO is a medicine that affects your immune system ENJAYMO may lower the ability of your immune system to fight infections ENJAYMO increases your chance of getting serious infections including those caused by encapsulated bacteria, including Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type B These serious
  • FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE
    ENJAYMO (sutimlimab-jome) is indicated for the treatment of hemolysis in adults with cold agglutinin disease (CAD) 2 DOSAGE AND ADMINISTRATION 2 1 Recommended Vaccinations Vaccinate patients against encapsulated bacteria at least 2 weeks prior to initiation of ENJAYMO therapy according to the most current Advisory Committee on Immunization
  • Enjaymo (sutimlimab): Uses, Side Effects, Dosage Reviews
    This is because Enjaymo (sutimlimab) can raise your risk for serious infections You must receive these vaccines at least 2 weeks before starting Enjaymo (sutimlimab) treatment If your provider decides you need to start Enjaymo (sutimlimab) right away, it's important to get these vaccines as soon as possible to prevent infections
  • ENJAYMO® (sutimlimab-jome) | What is ENJAYMO?
    Serious Infections: ENJAYMO is a prescription medicine that affects your immune system ENJAYMO may lower the ability of your immune system to fight infections ENJAYMO increases your chance of getting serious infections including those caused by encapsulated bacteria, including Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type B





中文字典-英文字典  2005-2009